Results 71 to 80 of about 489,988 (278)

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Preparation of Non-Dairy Soft Ice Milk with Soy Milk

open access: yes, 2017
<p>This study examined the influence of different ratios of soy milk replacement of skim milk (the levels of 0:100, 25:75, 50:50, 75:25 and 100:0 soy milk to skim milk) on the chemical, physical, microbiological and sensory properties of soft ice ...
Hassan Barakat, Atallah A Atallah
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Croissance des agneaux Djallonkes Nourris avec du lait de soja [PDF]

open access: yesTropicultura, 2016
Growth of Djallonke Lambs fed with Soy Milk. Soy milk was administered to Djallonke Lambs in pre weaning. Three groups of 20 animals, all from a traditional extensive farming, were performed. Group 1 (control) was deprived of soy milk. In the 2nd and 3rd
Toukourou, Y.   +3 more
doaj  

PENGARUH PENAMBAHAN BERBAGAI JENIS SUSU TERHADAP KARAKTERISTIK SOYGHURT

open access: yesAgrointek, 2016
Soyghurt is a kind of yogurt as functional food product obtained from the fermentation of lactic acid bacteria in soy milk. The fermentation process of soy milk is different from cow's milk fermentation, because of different carbohydrate content ...
Mustika Nuramalia Handayani   +1 more
doaj   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

IS SOY MILK? THE ECONOMICS OF THE SOY MILK MARKET [PDF]

open access: yes
This study uses revealed preferences of consumers to study the consumer benefits from soy milk. The study specifies and estimates structural demand and reduced form models of competition for different milk types using US supermarket scanner data.
Foltz, Jeremy D., Dhar, Tirtha Pratim
core  

Soy Protein for Milk Replacers

open access: yesJournal of Dairy Science, 1975
Abstract Fully-cooked soy flour contains an inactive form of trypsin inhibitor that is converted to an active form in the pH range of 7 to 9. This inhibitor can be destroyed by heating the soy flour in water, but the extent of destruction appears to be partially dependent on the concentration of flour in the water.
H.A. Ramsey, T.R. Willard
openaire   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy